BNP Paribas Financial Markets’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $387 | Hold |
352
| – | – | ﹤0.01% | 5704 |
|
|
2026
Q1 | $612 | Hold |
352
| – | – | ﹤0.01% | 5521 |
|
|
2025
Q4 | $612 | Sell |
352
-10,634
| -97% | -$23.4K | ﹤0.01% | 5461 |
|
|
2025
Q3 | $25.7K | Buy |
10,986
+1,123
| +11% | +$2.15K | ﹤0.01% | 4845 |
|
|
2025
Q2 | $20.1K | Buy |
9,863
+7,632
| +342% | +$14.6K | ﹤0.01% | 4605 |
|
|
2025
Q1 | $3.64K | Sell |
2,231
-1,080
| -33% | -$2.17K | ﹤0.01% | 4902 |
|
|
2024
Q4 | $6.06K | Sell |
3,311
-2,370
| -42% | -$10.5K | ﹤0.01% | 4905 |
|
|
2024
Q3 | $32.8K | Buy |
5,681
+3,630
| +177% | +$29.9K | ﹤0.01% | 3691 |
|
|
2024
Q2 | $16.6K | Buy |
2,051
+1,745
| +570% | +$18.4K | ﹤0.01% | 3661 |
|
|
2024
Q1 | $4.25K | Sell |
306
-194
| -39% | -$1.68K | ﹤0.01% | 3753 |
|
|
2023
Q4 | $3.06K | Sell |
500
-434
| -46% | -$2.14K | ﹤0.01% | 3788 |
|
|
2023
Q3 | $4.36K | Sell |
934
-13,916
| -94% | -$76.9K | ﹤0.01% | 3672 |
|
|
2023
Q2 | $79.6K | Sell |
14,850
-59,726
| -80% | -$481K | ﹤0.01% | 3334 |
|
|
2023
Q1 | $734K | Buy |
74,576
+32,633
| +78% | +$556K | ﹤0.01% | 2510 |
|
|
2022
Q4 | $785K | Sell |
41,943
-8,874
| -17% | -$201K | ﹤0.01% | 2305 |
|
|
2022
Q3 | $1.05M | Buy |
50,817
+46,204
| +1,002% | +$1.18M | ﹤0.01% | 2451 |
|
|
2022
Q2 | $95.8K | Buy |
4,613
+2,740
| +146% | +$77.2K | ﹤0.01% | 3368 |
|
|
2022
Q1 | $80.7K | Sell |
1,873
-4,744
| -72% | -$214K | ﹤0.01% | 3424 |
|
|
2021
Q4 | $396K | Buy |
6,617
+2,240
| +51% | +$179K | ﹤0.01% | 3117 |
|
|
2021
Q3 | $376K | Buy |
4,377
+2,303
| +111% | +$231K | ﹤0.01% | 2857 |
|
|
2021
Q2 | $231K | Buy |
2,074
+159
| +8% | +$15.3K | ﹤0.01% | 2835 |
|
|
2021
Q1 | $213K | Sell |
1,915
-2,894
| -60% | -$381K | ﹤0.01% | 3015 |
|
|
2020
Q4 | $511K | Sell |
4,809
-16,197
| -77% | -$2.16M | ﹤0.01% | 2449 |
|
|
2020
Q3 | $2.92M | Buy |
21,006
+19,556
| +1,349% | +$4.08M | ﹤0.01% | 1328 |
|
|
2020
Q2 | $469K | Sell |
1,450
-954
| -40% | -$153K | ﹤0.01% | 2126 |
|
|
2020
Q1 | $215K | Buy |
2,404
+1,508
| +168% | +$93K | ﹤0.01% | 2817 |
|
|
2019
Q4 | $35.5K | Sell |
896
-279
| -24% | -$8.4K | ﹤0.01% | 3822 |
|
|
2019
Q3 | $28.9K | Buy |
1,175
+373
| +47% | +$11.3K | ﹤0.01% | 3772 |
|
|
2019
Q2 | $28.3K | Sell |
802
-716
| -47% | -$28.4K | ﹤0.01% | 3758 |
|
|
2019
Q1 | $67.9K | Buy |
1,518
+1,515
| +50,500% | +$76.4K | ﹤0.01% | 3345 |
|
|
2018
Q4 | $124 | Sell |
3
-252
| -99% | -$15.3K | ﹤0.01% | 4159 |
|
|
2018
Q3 | $17K | Hold |
255
| – | – | ﹤0.01% | 3483 |
|
|
2018
Q2 | $12K | Sell |
255
-1,235
| -83% | -$68.1K | ﹤0.01% | 3705 |
|
|
2018
Q1 | $84.2K | Buy |
1,490
+29
| +2% | +$1.57K | ﹤0.01% | 3281 |
|
|
2017
Q4 | $72.4K | Buy |
1,461
+879
| +151% | +$54.5K | ﹤0.01% | 3470 |
|
|
2017
Q3 | $44.3K | Sell |
582
-44
| -7% | -$3.27K | ﹤0.01% | 3206 |
|
|
2017
Q2 | $58.9K | Buy |
626
+588
| +1,547% | +$50.3K | ﹤0.01% | 3105 |
|
|
2017
Q1 | $3.01K | Sell |
38
-60
| -61% | -$4.78K | ﹤0.01% | 3428 |
|
|
2016
Q4 | $8.18K | Sell |
98
-284
| -74% | -$25.7K | ﹤0.01% | 3541 |
|
|
2016
Q3 | $42.7K | Buy |
382
+167
| +78% | +$18.5K | ﹤0.01% | 2500 |
|
|
2016
Q2 | $23.8K | Buy |
+215
| New | +$26.1K | ﹤0.01% | 2518 |
|
|
2016
Q1 | – | Sell |
-1,313
| Closed | -$106K | – | 2866 |
|
|
2015
Q4 | $106K | Buy |
1,313
+76
| +6% | +$6.05K | ﹤0.01% | 2294 |
|
|
2015
Q3 | $85.8K | Buy |
1,237
+739
| +148% | +$64.4K | ﹤0.01% | 2487 |
|
|
2015
Q2 | $48.7K | Buy |
498
+379
| +318% | +$40.5K | ﹤0.01% | 2509 |
|
|
2015
Q1 | $11.7K | Buy |
+119
| New | +$11.5K | ﹤0.01% | 2668 |
|
|
2014
Q4 | – | Sell |
-297
| Closed | -$35.2K | – | 2573 |
|
|
2014
Q3 | $35.2K | Buy |
+297
| New | +$37K | ﹤0.01% | 2808 |
|
Other funds holding INO
VCM
EP
VFT
CM
GCP
BNP Paribas Financial Markets's INO Position: Q2 2026 in Review
BNP Paribas Financial Markets held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 352 shares worth $387. The position accounts for ﹤0.01% of the portfolio, ranked #5704.
BNP Paribas Financial Markets first reported a position in INO in Q3 2014 and has held it in 46 quarters since. The position peaked at $2.92M in Q3 2020. 94 funds tracked by Wall St. Rank hold INO as of Q2 2026.
- BNP Paribas Financial Markets held 352 shares of Inovio Pharmaceuticals worth $387 as of Q2 2026.
- BNP Paribas Financial Markets left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
- Inovio Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5704 holding.
- BNP Paribas Financial Markets first reported a position in Inovio Pharmaceuticals in Q3 2014 and has held it in 46 quarters since.
- BNP Paribas Financial Markets's Inovio Pharmaceuticals position peaked at $2.92M in Q3 2020.
- 94 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.